8 SAFETY OF TELAPREVIR OR BOCEPREVIR IN COMBINATION WITH PEGINTERFERON ALFA/RIBAVIRIN, IN CIRRHOTIC NON RESPONDERS. FIRST RESULTS OF THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)
- 30 April 2012
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: